A Phase I/II Study for the Safety and Efficacy of Panitumumab in Combination With TAS-102 for Patients With Colorectal Cancer
Clinical trial NCT02613221 · COMPLETED
Trial details
- NCT number
- NCT02613221
- Sponsor
- Takeda
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-07
- Primary completion
- 2017-10-06
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.